| Literature DB >> 17466068 |
Marie-Louise Essink-Bot1, Marja C Stuifbergen, Willem-Jan Meerding, Caspar W N Looman, Gouke J Bonsel.
Abstract
BACKGROUND: The effects of socio-demographic characteristics of the respondent, including age, on valuation scores of hypothetical health states remain inconclusive. Therefore, we analyzed data from a study designed to discriminate between the effects of respondents' age and time preference on valuations of health states to gain insight in the contribution of individual response patterns to the variance in valuation scores.Entities:
Mesh:
Year: 2007 PMID: 17466068 PMCID: PMC1868724 DOI: 10.1186/1472-6963-7-62
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
EuroQol 5D+ classification of health
| Dimension | Level | Code |
| Mobility | No problems in walking about | 1 |
| Some problems in walking about | 2 | |
| Confined to bed | 3 | |
| Self-care | No problems with washing or dressing self | 1 |
| Some problems with washing and dressing self | 2 | |
| Unable to wash or dress self | 3 | |
| Usual activities | No problems with performing usual activities (study, housework, family or leisure activities) | 1 |
| Some problems with performing usual activities | 2 | |
| Unable to perform daily activities | 3 | |
| Pain/discomfort | No pain or discomfort | 1 |
| Moderate pain or discomfort | 2 | |
| Extreme pain or discomfort | 3 | |
| Anxiety/depression | Not anxious or depressed | 1 |
| Moderately anxious or depressed | 2 | |
| Extremely anxious or depressed | 3 | |
| Cognition | No problems in cognitive functioning (e.g. memory, concentration, coherence, IQ) | 1 |
| Some problems in cognitive functioning | 2 | |
| Extreme problems in cognitive functioning | 3 |
Mean respondent age (range) by age group and gender
| male | female | total sample | ||||
| n | mean age (range*) | n | mean age (range*) | n | mean age | |
| Age group 1 | 27 | 22.9 (19–26) | 36 | 22.0 (17–28) | 63 | 22.4 |
| Age group 2 | 33 | 46.3 (39–50) | 39 | 46.8 (41–53) | 72 | 46.6 |
| Age group 3 | 27 | 63.3 (60–72) | 25 | 61.6 (55–65) | 52 | 62.5 |
* ages of some respondents were outside the limits of the age groups approximately aimed at in the recruitment phase (see Methods)
Mean scores (range), standard deviation, median and interquartile range of valuations of health states for VAS and two TTO variants, ranked from highest to lowest valuation.
| Mean (range) | SD | Median | Interquartile range | |
| 112121 | 0.781 (0.20 – 1.00) | 0.13 | 0.80 | 0.75 – 0.85 |
| 222111 | 0.701,2 (0.25 – 0.98) | 0.15 | 0.70 | 0.65 – 0.80 |
| 122122 | 0.59 (0.10 – 1.00) | 0.17 | 0.60 | 0.50 – 0.70 |
| 123121 | 0.57 (0.20 – 1.00) | 0.15 | 0.60 | 0.50 – 0.65 |
| 332221 | 0.411 (0.00 – 1.00) | 0.19 | 0.40 | 0.30 – 0.50 |
| 222223 | 0.381,2 (0.00 – 1.00) | 0.22 | 0.35 | 0.25 – 0.50 |
| 112121 | 0.701,3 (0.03 – 0.98) | 0.25 | 0.78 | 0.53 – 0.93 |
| 222111 | 0.681,3 (0.03 – 0.98) | 0.25 | 0.73 | 0.53 – 0.88 |
| 122122 | 0.533 (0.03 – 0.98) | 0.29 | 0.53 | 0.28 – 0.78 |
| 123121 | 0.493 (0.03 – 0.98) | 0.30 | 0.53 | 0.23 – 0.73 |
| 332221 | 0.321,3 (0.03 – 0.98) | 0.29 | 0.28 | 0.25 – 0.48 |
| 222223 | 0.241 (0.03 – 0.98) | 0.28 | 0.08 | 0.25 – 0.43 |
| 112121 | 0.803 (0.08 – 0.98) | 0.18 | 0.88 | 0.68 – 0.98 |
| 222111 | 0.762,3 (0.03 – 0.98) | 0.20 | 0.78 | 0.68 – 0.93 |
| 122122 | 0.603 (0.03 – 0.98) | 0.27 | 0.63 | 0.48 – 0.88 |
| 123121 | 0.583 (0.03 – 0.98) | 0.27 | 0.58 | 0.48 – 0.78 |
| 332221 | 0.383 (0.03 – 0.98) | 0.30 | 0.38 | 0.03 – 0.63 |
| 222223 | 0.232 (0.03 – 0.98) | 0.26 | 0.08 | 0.03 – 0.48 |
1significant difference VAS-TTO-LE
2significant difference VAS – TTO-10
3significant difference TTO-LE – TTO-10
Figure 1Mean valuation scores per age group (age group 1, mean age 22 years; age group 2, mean age 47 years; age group 3, mean age 63 years) per elicitation method: visual analogue scale (VAS), time trade-off with 10 years (TTO-10) and time trade-off with life expectancy (TTO-LE).
G-study on all elicitation methods collectively, incorporating the facets 'health state' (6 levels), 'method' (3 levels), 'age group' (3 levels) and 'respondent' (nested under age; 187 levels) and their interaction terms
| % variance explained | |
| Health state | 36.8 |
| Method | 1.6 |
| Age group | 0.2 |
| Respondent [age group] | 11.1 |
| Health state * Method | 1.4 |
| Health state * Age group | 0.0 |
| Health state * Respondent [age group] | 8.9 |
| Method * Age group | 0.0 |
| Method * Respondent [age group] | 17.3 |
| Error | 23.2 |
[age group] means 'nested under age group'.
Deviation, and direction of deviation, from the mean valuation scores in clusters found with Cluster Analysis (differences ≥ 0.20 marked in bold)
| Cluster (n) | |||||||||
| 1 (27) | 2 (22) | 3 (11) | 4 (23) | 5 (27) | 6 (20) | 7 (22) | 8 (19) | 9 (16) | |
| VAS | |||||||||
| 112121 | -0.06 | 0.01 | -0.01 | 0.02 | 0.00 | 0.01 | -0.01 | 0.03 | 0.01 |
| 222111 | -0.10 | 0.01 | 0.07 | 0.03 | 0.02 | 0.00 | 0.01 | 0.05 | -0.06 |
| 122122 | -0.16 | -0.01 | 0.17 | -0.01 | -0.02 | 0.03 | -0.05 | 0.15 | 0.02 |
| 123121 | -0.05 | -0.03 | 0.14 | 0.07 | -0.07 | -0.02 | -0.04 | 0.12 | -0.03 |
| 332221 | -0.06 | -0.09 | 0.10 | -0.05 | -0.08 | -0.01 | 0.12 | -0.03 | |
| 222223 | -0.14 | -0.03 | -0.08 | -0.09 | 0.02 | 0.00 | -0.04 | ||
| TTO-LE. | |||||||||
| 112121 | 0.08 | 0.14 | 0.11 | 0.06 | -0.13 | ||||
| 222111 | 0.03 | 0.18 | 0.15 | 0.20 | -0.07 | -0.18 | |||
| 122122 | 0.16 | 0.13 | 0.02 | 0.03 | -0.17 | ||||
| 123121 | -0.03 | -0.19 | 0.11 | -0.16 | -0.18 | ||||
| 332221 | 0.15 | -0.01 | 0.07 | -0.14 | |||||
| 222223 | -0.13 | -0.14 | 0.04 | 0.05 | -0.16 | -0.18 | |||
| TTO-10 | |||||||||
| 112121 | 0.12 | 0.14 | 0.11 | -0.02 | 0.11 | 0.04 | -0.07 | -0.03 | |
| 222111 | 0.16 | 0.09 | 0.15 | -0.04 | 0.10 | -0.01 | -0.06 | -0.03 | |
| 122122 | 0.02 | -0.11 | 0.17 | 0.06 | -0.15 | 0.11 | |||
| 123121 | 0.16 | -0.13 | 0.00 | 0.06 | -0.12 | 0.11 | |||
| 332221 | 0.14 | -0.15 | - | 0.08 | |||||
| 222223 | -0.15 | -0.03 | 0.15 | -0.13 | -0.00 | ||||